Lot Release Certificate View

Lot Release Number 2021-03-02-0095
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Poliomyelitis (Inactivated) Vaccine and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTaP-IPV and HiB]
Brand Name PENTAXIM
Dosage Strength -
Dosage Form Suspension and Powder for Suspension for Injection (IM)
Registration Number BR-523
Batch/Lot Number U0D211V
Packaging Lot Packaging Lot (Box): U0D211V; (Vial): T3K73; Pre-Filled Syringe: U0D211V/ T3K30
Product Expiration Date March 2022
Issuance Date 04 March 2021